Wen Wei

发表

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays

E. Nexo, A. Khalil, B. Sorensen, 2014, BMC Cancer.

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome.

Torsten Haferlach, Alexander Kohlmann, Wolf-Karsten Hofmann, 2009, Blood.

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

K. Bloom, W. Maltzman, S. Anderson, 2013, BMC Cancer.

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

P. Jänne, D. Haber, L. Sequist, 2015, Clinical Cancer Research.

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma

L. Shao, Wen Wei, L. Dong, 2022, Frontiers in Oncology.

Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Sensitizing and Resistance Mutations in the Plasma DNA of Patients With Advanced Non–Small Cell Lung Cancer During Treatment With Erlotinib

E. Nexo, B. Weber, P. Meldgaard, 2014, Cancer.

Performance Characteristics of a Real-Time Polymerase Chain Reaction Assay for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Plasma Samples of Non-Small Cell Lung Cancer (NSCLC) Patients

S. Scudder, Wen Wei, K. Yu, 2020, Molecular Diagnosis & Therapy.

Abstract 1707: A real-time PCR assay for detecting EGFR mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of non-small cell lung cancer (NSCLC)

R. Current, S. Soviero, J. Shyu, 2012 .